Sivik Global Healthcare LLC Has $7.42 Million Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Sivik Global Healthcare LLC decreased its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 8.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 230,000 shares of the company’s stock after selling 20,000 shares during the period. Surgery Partners makes up about 3.1% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 12th biggest holding. Sivik Global Healthcare LLC’s holdings in Surgery Partners were worth $7,415,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Quarry LP raised its stake in shares of Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares in the last quarter. KBC Group NV increased its holdings in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after buying an additional 576 shares during the period. DekaBank Deutsche Girozentrale raised its stake in shares of Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares in the last quarter. EntryPoint Capital LLC boosted its position in shares of Surgery Partners by 257.1% during the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after acquiring an additional 4,607 shares in the last quarter. Finally, Creative Planning acquired a new stake in shares of Surgery Partners during the 3rd quarter valued at about $258,000.

Analyst Ratings Changes

SGRY has been the subject of a number of analyst reports. StockNews.com cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Citigroup cut their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Benchmark reiterated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research report on Monday, August 26th. Royal Bank of Canada reiterated an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research note on Friday, October 4th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Surgery Partners presently has an average rating of “Moderate Buy” and an average target price of $40.00.

Surgery Partners Stock Performance

Surgery Partners stock opened at $25.66 on Thursday. The stock has a 50-day simple moving average of $30.88 and a 200 day simple moving average of $28.47. The stock has a market capitalization of $3.26 billion, a price-to-earnings ratio of -53.14, a P/E/G ratio of 2.34 and a beta of 2.76. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96. Surgery Partners, Inc. has a 12-month low of $22.25 and a 12-month high of $36.92.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.